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EDITORIAL
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eThe  original  isolation  of  the  Zika  virus  (ZIKV),  a  Flavivirus
member  of  the  Flaviviridae  family,  was  obtained  in  1947
from  the  blood  of  a  febrile  rhesus  monkey  exposed  at  the
Zika  forest  near  Lake  Victoria,  in  the  outskirts  of  Entebbe,
the  capital  of  Uganda.1 ZIKV  was  also  isolated  from  wild
mosquitoes  in  the  same  area  and  later  periodic  human
febrile  cases  were  attributed  to  ZIKV  in  Uganda  and  other
countries  in  West  and  East  Africa.  Later,  in  the  1960s,  ZIKV
was  detected  in  Asia  and  the  virus  was  isolated  from  Aedes
aegypti  mosquitoes,  initially  in  Malaysia  and,  subsequently,
in  several  countries  in  Asia,  showing  that  this  arbovirus  also
occurred  outside  the  African  continent.2 This  new  facet  of
ZIKV,  i.e., ability  to  cause  epidemic  disease  transmitted  by
Aedes  aegypti,  disclosed  a  new  milestone  in  the  epidemi-
ology  of  this  arbovirus  infection.  It  was  clear  that  ZIKV  had
managed  to  adapt  to  an  old  acquaintance  of  humans,  Aedes
aegypti  mosquitoes,  transmitters  of  urban  yellow  fever,  four
serotypes  of  dengue  fever,  chikungunya  virus,  and  other
arboviruses  in  Asia  and  Africa.
Since  the  1960s,  sporadic  cases  of  ZIKV  infection  have
been  reported  in  humans3;  due  to  its  sporadic  occurrence
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0021-7557/© 2016 Sociedade Brasileira de Pediatria. Published by Elsevind  low  severity  pattern,  little  importance  was  given  to  this
rbovirus  until  a  Zika  fever  epidemic  occurred  on  Yap  Island
n  the  Republic  of  Micronesia  in  2007,  with  the  description
f  a  rash  febrile  syndrome  of  mild  intensity  and  a  high  per-
entage  of  asymptomatic  cases.4 This  episode  on  Yap  Island
as  followed  by  others,  in  the  Paciﬁc  Ocean  region  of  Poly-
esia  and  in  some  Southeast  Asian  countries,  with  outbreaks
onﬁrmed  by  serology  or  polymerase  chain  reaction  (PCR)
or  the  ZIKV  on  Easter  Island,  and  in  the  Solomon  Islands,
he  Cook  Islands,  Indonesia,  Malaysia,  Thailand,  and  French
olynesia.5--7 In  the  latter,  retrospective  epidemiological
tudies  suggested  the  occurrence  of  approximately  30,000
nfections  and,  for  the  ﬁrst  time,  cases  of  Guillain-Barre
yndrome  (GBS)  were  observed  associated  with  ZIKV  infec-
ion,  as  well  as  the  notiﬁcation  of  the  ﬁrst  cases  of  perinatal
ransmission,8 warning  of  the  potential  complications  of
ongenital  arbovirus  infections,  based  on  previous  reports  of
ncephalopathy,  hemorrhagic  fever,  and  fetal  death,  among
thers,  associated  with  chikungunya  and  dengue  viruses.  In
 retrospective  analysis  of  live  births  during  this  outbreak
n  Polynesia,  17  cases  of  central  nervous  system  malfor-
ations,  including  microcephaly  in  fetuses  and  newborns,
ere  identiﬁed  from  March  2014  to  May  2015.  None  of  the
regnant  women  reported  signs  of  ZIKV  infection,  but  anti-
odies  (IgG)  to  Flavivirus  were  found  in  four  women  tested
y  serology,  suggesting  asymptomatic  infection.9 Similarly
s  in  Brazil,  French  Polynesia  health  authorities  also  believe
er Editora Ltda. All rights reserved.
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hat  ZIKV  may  be  associated  with  birth  defects  if  pregnant
omen  are  infected  during  the  ﬁrst  or  second  trimester  of
regnancy.
After  the  conﬁrmation  of  the  ﬁrst  cases  of  Zika  fever  in
razil  in  May  2015,  initially  in  the  Northeast,10 there  was
 rapid  spread  of  the  virus  to  other  parts  of  the  coun-
ry,  followed  by  the  signiﬁcant  increase  in  notiﬁcations  of
ewborns  with  microcephaly  in  the  Brazilian  Live  Birth  Infor-
ation  System  (Sistema  de  Informac¸ão  de  Nascidos  Vivos
SINASC]),  with  the  recording  of  141  suspected  cases  of
icrocephaly  in  November  2015  in  the  state  of  Pernambuco,
fter  which  an  excessive  number  of  cases  in  other  northeast-
rn  states  (Paraíba  and  Rio  Grande  do  Norte)  were  detected,
n  addition  to  the  records  of  miscarriages  and  stillbirths.
aced  with  this  new  scenario,  the  Ministry  of  Health  of
razil  declared  the  event  as  a  public  health  emergency  of
ational  concern.11 It  was  also  veriﬁed  that  the  ﬁrst  months
f  pregnancy  of  children  born  with  microcephaly  matched
he  largest  period  of  circulation  of  the  ZIKV  in  the  North-
ast,  and  there  was  no  correlation  with  family  history  of
enetic  disease,  or  tests  demonstrating  a  pattern  of  other
nown  infectious  processes.
The  causal  association  was  carried  out  by  Instituto
vandro  Chagas  (IEC)  of  the  Ministry  of  Health  through
he  isolation  the  ZIKV  from  brain  tissue  and  detection  of
he  virus  in  cerebral  spinal  ﬂuid  (CSF),  brain  tissue,  and
ragments  of  several  viscera  (heart,  lungs,  liver,  spleen
nd  kidney)  of  a  newborn  that  died  shortly  after  birth.11
ubsequently,  these  results  were  reinforced  with  the
etection  of  IgM  antibodies  to  ZIKV  in  the  CSF  of  12  children
orn  with  microcephaly.  All  tests  for  other  infectious
gents  associated  with  what  is  medically  known  as  TORCH
yndrome  (toxoplasma  gondii,  other  agents,  rubella  virus,
ytomegalovirus,  and  herpes  simplex  virus,  types  1  and  2),
s  well  as  dengue  and  chikungunya,  were  negative  (Azevedo
t  al.;  personal  communication).
Another  important  contribution  to  elucidate  the  causal
ssociation  was  the  identiﬁcation  of  ZIKV  the  amniotic  ﬂuid
f  two  pregnant  women  from  the  state  of  Paraiba  with
 history  of  rash  illness  and  fetuses  with  microcephaly
etected  at  the  fetal  ultrasonography.12 After  this  ﬁnding,
urther  studies  were  conducted,  which  allowed  the  com-
lete  sequencing  of  the  virus  isolated  from  the  amniotic
uid,  with  the  phylogenetic  analysis  disclosing  that  the  virus
hares  97-100%  of  its  genomic  identity  with  the  Asian  strain
solated  during  the  outbreak  in  French  Polynesia  and  that
he  presence  of  the  viral  genome  in  the  patients  for  a  few
eeks  after  the  acute  phase  suggests  that  the  intrauterine
iral  load  results  from  persistent  replication.13 As  additional
vidence,  the  identiﬁcation  of  the  ZIKV  genome  in  placen-
al  cells  in  an  8-week  miscarriage  using  RT-PCR  techniques
einforced  the  potential  of  placental  transmission.14
Recently,  the  Centers  for  Disease  Control  and  Prevention
CDC)  conﬁrmed  the  presence  of  the  virus,  using  RT-PCR  and
mmunohistochemistry,  in  the  brain  tissue  of  four  newborns
ith  microcephaly  and/or  severe  brain  malformations  that
ied  after  birth,  and  in  the  placentas  of  miscarried  fetuses  at
2  weeks  of  gestation.15 Similar  ﬁndings  were  identiﬁed  by
lakar  et  al.,16 who  identiﬁed  the  viral  genome  in  the  brain
nd  placenta  of  a  fetus  miscarried  in  the  32nd  week  of  gesta-
ion  that  had  multiple  brain  lesions  and  intrauterine  growth
etardation  detected  after  the  29th  week  of  gestation,
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hich  conﬁrms  the  virus  neurotropism,  with  a  possible  viral
ersistence  in  brain  tissue  and  severe  placental  impairment.
Furthermore,  there  has  been  increasing  evidence  that  in
ddition  to  the  brain,  the  eyes  would  be  the  next  target
rgan  of  ZIKV,  as  the  presence  of  ocular  disorders  (macular
trophy)  has  been  observed  in  children  with  microcephaly17
nd,  more  recently,  macular  and  perimacular  lesions  with
ptic  nerve  atrophy,18 as  described  in  ten  children  with
icrocephaly  during  the  Zika  outbreak  in  the  capital  city
f  Salvador,  state  of  Bahia.
Considering  the  severity  of  the  situation,  the  rapid  spread
f  ZIKV  in  the  American  continent,  and  the  difﬁculties  of
iagnosis  for  an  emerging  arbovirus  infection  in  the  Ameri-
as,  as  well  as  the  high  risk  of  the  virus  spreading  to  other
ontinents,  the  WHO  declared  the  ZIKV  epidemic  an  impor-
ant  international  public  health  event,  according  to  the
nternational  Health  Regulations,  and  convened  an  emer-
ency  committee.  The  disclosure  of  the  WHO  note  was
ollowed  by  a  description  of  the  event.19
One  of  the  major  limitations  to  be  overcome  is  the  lack  of
ommercial  serological  and  molecular  tests  for  the  diagnosis
f  ZIKV,  as  the  existing  in-house  tests  are  currently  limited
o  reference  laboratories,  which  are  unable  to  meet  the
emands  of  public  health  laboratories.  In  fact,  there  is  an
rgent  necessity  to  develop  rapid  tests  (immunochromato-
raphic),  serological  (IgM-  and  IgG-ELISA)  and  molecular
ests  for  the  early  diagnosis  of  ZIKV  infection,  especially  for
he  most  vulnerable  groups,  i.e., pregnant  women  and  indi-
iduals  with  autoimmune  conditions  and  chronic  diseases.20
here  have  been  recent  records  of  deaths  in  patients  with
hronic  diseases,  lupus,  hemolytic  anemia,  sickle-cell  ane-
ia,  and  others,  which  means  these  groups  should  have
rioritized  access  to  the  diagnosis  of  ZIKV  infection.
There  is  a  clear  need  to  reinforce  antivectorial  measures,
hich  is  the  only  currently  available  concrete  measure  to
educe  cases  of  ZIKV  infections.  It  is  urgent  that  concrete
ctions  be  taken  at  all  public  levels  together  with  the  par-
icipation  of  society  to  reduce  vector  infestation  indices;  by
educing  the  number  of  vectors,  we  will  reduce  incidence
ates  and,  obviously,  the  number  of  cases  of  microcephaly
nd  other  congenital  malformations.
The  Brazilian  Ministry  of  Health  made  the  political  deci-
ion  to  develop  a  vaccine  against  ZIKV.  Regarding  this
ubject,  there  are  several  possible  approaches  to  the  devel-
pment  of  a  vaccine  to  prevent  ZIKV  infection,  which
nclude:  inactivated  virus  vaccine,  attenuated  live  virus  vac-
ine,  chimeric  live  virus  vaccine,  DNA  vaccine,  and  subunit
accine.  Undoubtedly,  the  subunit  and  DNA  vaccines  are
hose  that  do  not  pose  risks  to  pregnant  women  and  special
roups,  and  can  be  obtained  quickly,  the  same  occurring  with
he  inactivated  virus  vaccine.  It  is  important  to  note,  how-
ver,  that  whatever  the  adopted  formulation  is,  pre-clinical
nd  clinical  trials  phases  I,  II,  and  III  will  take  some  years
ntil  a  licensed  product  for  use  in  humans  is  obtained.
In  conclusion,  the  emergence  of  an  ‘‘almost  unknown’’
rbovirus  and  its  causal  association  with  different  clin-
cal  manifestations  and  a  degree  of  severity,  especially
bserved  in  fetuses  and  adults  with  immune  suppression
nd  autoimmune  disorders,  opens  up  a  range  of  opportuni-
ies  for  many  studies,  but  the  perspective  of  dissemination
f  this  arbovirus  to  other  continents  in  a  globalized  world
ill  require  a prompt  response  coordinated  by  the  WHO,
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